Compare PGEN & DRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | DRD |
|---|---|---|
| Founded | 1998 | 1895 |
| Country | United States | South Africa |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | 2013 | 2002 |
| Metric | PGEN | DRD |
|---|---|---|
| Price | $7.13 | $30.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | $8.33 | ★ $32.63 |
| AVG Volume (30 Days) | ★ 6.0M | 269.4K |
| Earning Date | 05-13-2026 | 08-19-2026 |
| Dividend Yield | N/A | ★ 2.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $230,981,000.00 | N/A |
| Revenue This Year | $1,115.92 | $39.23 |
| Revenue Next Year | $81.04 | $30.12 |
| P/E Ratio | $248.00 | ★ $15.32 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.99 | $17.51 |
| 52 Week High | $7.49 | $39.37 |
| Indicator | PGEN | DRD |
|---|---|---|
| Relative Strength Index (RSI) | 62.70 | 81.34 |
| Support Level | $3.96 | $29.40 |
| Resistance Level | $7.32 | $30.69 |
| Average True Range (ATR) | 0.44 | 0.81 |
| MACD | 0.02 | 0.83 |
| Stochastic Oscillator | 75.70 | 91.57 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.